Life Sciences compliance news

Browse by Tags

• Kohl Hearing Examines Direct-To-Consumer Advertising For Medical Devices; Considers Mandatory Review And Moratoriums

  U.S. Senate Special Committee on Aging Chairman Herb Kohl (D-WI) held a hearing examining issues related to direct-to-consumer (DTC) advertising for restricted medical devices that are regulated by the Food and Drug Administration (FDA), such as heart... Posted Sep 19 2008, 08:26 AM by CyberWatcher Newsfeed - Life Sciences News Filed under: MediLexicon

• Sunshine Heart Announces IDE Approval To Begin C-Pulse U.S. Clinical Feasibility Trial

  Sunshine Heart (ASX: SHC), a global medical device company focused on innovative heart assist technologies, announced that it has received conditional approval of an Investigational Device Exemption (IDE) from the U.S. Food and Drug Administration (FDA... Posted Sep 13 2008, 08:15 AM by CyberWatcher Newsfeed - Life Sciences News Filed under: MediLexicon

• Democrats Opposing Supreme Court Decision In Favor Of Pre-Emption Pandering To Tort Lawyers, Wall Street Journal Editorial Says

  The's "sensible" 8-1 ruling in the case of, stating that medical devices approved byare exempt from product liability lawsuits in state courts, "makes sense for many reasons" but has "nonetheless sent up yowls" from Democratic... Posted Aug 14 2008, 01:21 PM by CyberWatcher Newsfeed - Life Sciences News Filed under: MediLexicon

• Reclassification Of Azithromycin From POM To P - An Unparalleled Opportunity, UK

  The NPA regards the switch of azithromycin from POM to P as an unparalleled opportunity for community pharmacy to become an alternative option for safe and effective treatment for chlamydia infection. Read More... Posted Aug 07 2008, 09:06 AM by CyberWatcher Newsfeed - Life Sciences News Filed under: MediLexicon